SCHEMBL7844447

SCHEMBL7844447

CCOC(=O)c1cc(=O)c2cc(F)c(F)c(C#N)c2n1C1CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.48
TOP2A P11388 1/20 0.41
TOP2B Q02880 1/20 0.41
ADRB2 P07550 1/20 0.40
KDM4E B2RXH2 6/20 0.37
GLA P06280 1/20 0.37
ATM Q13315 1/20 0.37
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 4/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23037281 0.89 TOP2A (0.47) STAT3TOP2ATOP2BADRB2KDM4E
SCHEMBL7122780 0.84 ALDH1A1 (0.43) STAT3TOP2ATOP2BADRB2KDM4E
SCHEMBL9561861 0.81 ADRB2 (0.43) STAT3TOP2ATOP2BADRB2KDM4E
SCHEMBL3549628 0.78 STAT3 (0.63) STAT3TOP2ATOP2BADRB2KDM4E
SCHEMBL1345175 0.77 STAT3 (0.44) STAT3TOP2ATOP2BADRB2NPC1
SCHEMBL7995325 0.77 STAT3 (0.36) STAT3ADRB2
SCHEMBL7842251 0.77 STAT3 (0.36) STAT3ADRB2
SCHEMBL7978648 0.75 STAT3 (0.59) STAT3TOP2ATOP2BADRB2ALDH1A1
SCHEMBL9564487 0.74 MEN1 (0.43) TOP2ATOP2BADRB2KDM4EUSP2
SCHEMBL8096676 0.72 TOP2A (0.47) TOP2ATOP2BKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010036941-A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders PETERSEN UWE (DE) 2001-11-01 US disclosed
US-6288081-B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith BAYER AKTIENGESELLSCHAFT (DE) 2001-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010036941-A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders OXER1, AOC3, PAM STAT3 1093/4885TOP2A 156/4885TOP2B 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.